Search

everythinglearnresearchcommunity

for

Search:↓

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

SA linked to mitochondrial issues and oxidative stress, while AGA involves disrupted hair growth genes.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Genetic variations affect dutasteride treatment response for male pattern hair loss.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Mice lacking the PPARγ gene in their fat cells had almost no fat tissue, severe metabolic problems, and abnormal development of other fat-related tissues.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.

Postpartum depression is linked to changes in brain chemicals, inflammation, stress, and certain genes, and can potentially be identified by markers like specific steroids, serotonin levels, and vitamin D levels.

Hair loss in women may have causes other than hormones.

Androgens increase muscle mass by promoting myoblast growth through ornithine decarboxylase.

Melatonin receptors, found in many body parts, can help treat various diseases like depression and diabetes due to their effects on inflammation, tumor progression, sleep disorders, and body mass regulation.

Autism's genetics are linked with early age of puberty and less hair loss, but not with hormone levels or polycystic ovary syndrome.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.

Chromosomal differences affect how muscle cells respond to testosterone.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Prolactin slows down hair growth in mice.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Higher DHT in male baldness may protect against prostate cancer.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

Hormones affect skin aging, and treatments targeting hormonal balance may improve skin health.

The document concludes that for hair and feather growth, it's better to target the environment around stem cells than the cells themselves.